MedTrace Logo

Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease

NCT07459582 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2026-06-01

No results posted yet for this study

Summary

The goal of this study is to determine if the Lactate Plus meter is accurate compared to lab lactate levels, and to determine if the Accu chek guide glucometer is accurate compared to lab serum glucose levels in patients with Glycogen Storage Disease Types Ia, Ib and XI.

To determine this, patient's will have a one-time planned admission to Connecticut Children's for approximately 8 hours and receive hourly blood draws as well as finger-sticks.

Conditions

  • Glycogen Storage Disease Type IA
  • Glycogen Storage Disease Type I
  • Glycogen Storage Disease Type IB
  • Glycogen Storage Disease Xi

Interventions

OTHER

Lactate Meter

Hourly blood lactate levels

DEVICE

Accu Chek

Hourly blood glucose levels

Sponsors & Collaborators

  • Global Center for Glycogen Storage Disease held at the Jewish Community Foundation

    collaborator UNKNOWN

  • Connecticut Children's Medical Center

    lead OTHER

Principal Investigators

  • Malaya Mount, MS, RD, CDN · Connecticut Children's

  • Rebecca Riba-Wolman, MD · Connecticut Children's

Eligibility

Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2027-03-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07459582 on ClinicalTrials.gov